Showing results (211-220 of 290) with videos related to
Sort By:
Pageof 29
BMC Complementary Medicine and Therapies|May 6, 2025
Chinese herbal medicines for rhinosinusitis: a text-mining study with comparisons to contemporary research and clinical guidanceJing Cui, Brian H May, Wenmin Lin, et al.European Review for Medical and Pharmacological Sciences|March 27, 2014
Characterization of an injectable chitosan-demineralized bone matrix hybrid for healing critical-size long-bone defects in a rabbit modelF Shuang, S-X Hou, Y-T Zhao, et al.Trials|July 2, 2011
Panax ginseng C.A Meyer root extract for moderate chronic obstructive pulmonary disease (COPD): study protocol for a randomised controlled trialCharlie C Xue, Johannah L Shergis, Anthony L Zhang, et al.European Review for Medical and Pharmacological Sciences|December 17, 2013
Endothelial progenitor cells are influenced by serum of patients with systemic inflammatory response syndrome or multiple organ dysfunctionT Pang, W Chen, Z-M Lu, et al.The Journal of Biological Chemistry|July 28, 1995
Characterization of irreversible binding of beta-funaltrexamine to the cloned rat mu opioid receptorC Chen, J C Xue, J Zhu, et al.Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|April 21, 2024
[Enhancing survival outcomes in stage Ⅲ gastric/esophagogastric junction cancer: a retrospective study of immune checkpoint inhibitors and adjuvant chemotherapy based on real-world data]X Q Yang, Z Rao, H K Wei, et al.Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|November 29, 2022
[HIV/AIDS surveillance in men who have sex with men aged 15-24 based on internet in Fuzhou,2016-2021]H Zhang, C Z Chen, S Y Lin, et al.Trials|July 8, 2015
Chinese herbal medicine granules (PTQX) for children with moderate to severe atopic eczema: study protocol for a randomised controlled trialSherman X Gu, Anthony L Zhang, Meaghan E Coyle, et al.Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|April 14, 2021
[Establishment of animal models of epidermal growth factor receptor inhibitor-related rashes]X Zhang, C Xue, J Li, et al.FEBS Letters|April 15, 1996
The region in the mu opioid receptor conferring selectivity for sufentanil over the delta receptor is different from that over the kappa receptorJ Zhu, J C Xue, P Y Law, et al.Pageof 29